Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Sunflower Pharmaceutical Group

Biomedical sector fell 0.91%, Miracle Pharmaceuticals rose 10.09% to top the list – yqqlm

  • Post date May 16, 2022 — 17:51 Post Lock Login to View

Read More

Sunflower Pharmaceutical: The actual controller Guan Yanbin plans to reduce his holdings by no more than 11.68 million shares

  • Post date May 14, 2022 — 09:50 Post Lock Login to View

Read More

Sunflower Pharmaceutical: The actual controller Guan Yanbin plans to reduce his holdings by no more than 11.68 million shares – yqqlm

  • Post date May 14, 2022 — 09:50 Post Lock Login to View

Read More

Sunflower Pharmaceutical: The actual controller Guan Yanbin plans to reduce his holdings by no more than 11.68 million shares

  • Post date May 14, 2022 — 09:50 Post Lock Login to View

Read More

Highlights of the announcement on the evening of May 13: China Life's accumulated original insurance premium income from January to April is about 343.5 billion yuan

  • Post date May 13, 2022 — 21:40 Post Lock Login to View

Read More

Chinese medicine sector opens up

  • Post date May 13, 2022 — 10:34 Post Lock Login to View

Read More

Biopharmaceutical sector rose 1.32%, Fudan Fuhua, Haipurui rose 10.04% to top the list – yqqlm

  • Post date May 12, 2022 — 18:16 Post Lock Login to View

Read More

3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews

  • Post date May 11, 2022 — 20:54 Post Lock Login to View

Read More

The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached)

  • Post date May 11, 2022 — 20:43 Post Lock Login to View

Read More

Mainland Stock Connect Masukan Ranking List (with shares)

  • Post date May 11, 2022 — 11:21 Post Lock Login to View

Read More

2 billion main funds have withdrawn from flu concept stocks in the past three days jqknews

  • Post date April 29, 2022 — 18:25 Post Lock Login to View

Read More

Dual brands drive Sunflower Pharmaceutical's revenue and non-net profit growth by nearly 30% in 2021 Xinhua

  • Post date April 26, 2022 — 21:05 Post Lock Login to View

Read More

Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm

  • Post date April 26, 2022 — 19:51 Post Lock Login to View

Read More

The concept of hepatitis continues to rise

  • Post date April 26, 2022 — 15:25 Post Lock Login to View

Read More

The concept of hepatitis continues to raise the daily limit of Qianhong Pharmaceutical and other pharmaceutical companies_Oriental Fortune Net

  • Post date April 26, 2022 — 15:24 Post Lock Login to View

Read More

The concept of hepatitis continues to raise the daily limit of Qianhong Pharmaceutical and others

  • Post date April 26, 2022 — 15:22 Post Lock Login to View

Read More

The concept of hepatitis continues to raise the daily limit of Qianhong Pharmaceutical and others_Securities News_Finance Gold Online

  • Post date April 26, 2022 — 15:20 Post Lock Login to View

Read More

Unexplained childhood hepatitis found in Japan! It has spread to 12 countries in Europe and the United States, and the A-share hepatitis sector has exploded! List of Concept Stocks-Stocks-Financial Industry

  • Post date April 26, 2022 — 15:10 Post Lock Login to View

Read More

Dual brands drive Sunflower Pharmaceutical's revenue and non-net profit growth by nearly 30% in 2021

  • Post date April 25, 2022 — 17:20 Post Lock Login to View

Read More

Dual brands drive Sunflower Pharmaceutical's 2021 revenue and non-net profit growth by nearly 30%

  • Post date April 25, 2022 — 17:18 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.